Synergy Pharmaceuticals Company Profile (NASDAQ:SGYP)

About Synergy Pharmaceuticals

Synergy Pharmaceuticals logoSynergy Pharmaceuticals Inc. (Synergy) is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The Company's GI platform includes two lead product candidates: plecanatide and dolcanatide. It is engaged in the discovery, research and development involving uroguanylin analogs for the treatment of functional GI disorders and inflammatory bowel disease. Plecanatide is the Company's uroguanylin analog being evaluated for use as a once-daily tablet for two functional GI disorders, chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Plecanatide is a 16-amino acid peptide that is structurally identical to uroguanylin with the exception of a single amino acid change. Dolcanatide is also its uroguanylin analog being explored for inflammatory bowel disease (IBD). Dolcanatide is designed to be an analog of uroguanylin with resistance to standard digestive breakdown by proteases in the intestine.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SGYP
  • CUSIP: 87163930
Key Metrics:
  • Previous Close: $4.78
  • 50 Day Moving Average: $4.40
  • 200 Day Moving Average: $3.66
  • 52-Week Range: $2.50 - $7.72
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -10.17
  • P/E Growth: 0.00
  • Market Cap: $857.75M
  • Outstanding Shares: 179,446,000
  • Beta: 674.11
Additional Links:
Companies Related to Synergy Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Synergy Pharmaceuticals (NASDAQ:SGYP) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $11.58 (142.33% upside)

Analysts' Ratings History for Synergy Pharmaceuticals (NASDAQ:SGYP)
DateFirmActionRatingPrice TargetDetails
8/25/2016BTIG ResearchInitiated CoverageBuy$11.00View Rating Details
8/13/2016Rodman & RenshawReiterated RatingBuy$15.00View Rating Details
7/17/2016Canaccord GenuityReiterated RatingBuy$13.00View Rating Details
5/26/2016Roth CapitalReiterated RatingBuy$6.50View Rating Details
3/16/2016Citigroup Inc.Lower Price TargetNeutral$7.00 -> $4.00View Rating Details
10/1/2015HC WainwrightReiterated RatingBuy$20.00View Rating Details
6/18/2015Cantor FitzgeraldReiterated RatingBuy$8.50 -> $14.00View Rating Details
9/12/2014Cowen and CompanyInitiated CoverageOutperformView Rating Details
(Data available from 8/30/2014 forward)


Earnings History for Synergy Pharmaceuticals (NASDAQ:SGYP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q216($0.20)($0.23)ViewN/AView Earnings Details
5/10/2016Q1($0.23)($0.51)ViewN/AView Earnings Details
11/9/2015Q315($0.28)($0.23)ViewN/AView Earnings Details
8/10/2015Q215($0.28)($0.34)$102.00 millionViewN/AView Earnings Details
5/11/2015Q115($0.33)($0.28)ViewN/AView Earnings Details
3/16/2015($0.28)($0.32)ViewN/AView Earnings Details
11/10/2014($0.28)($0.24)ViewN/AView Earnings Details
8/11/2014($0.23)($0.28)ViewN/AView Earnings Details
5/13/2014Q114($0.23)($0.18)ViewN/AView Earnings Details
3/17/2014Q4 13($0.20)($0.22)ViewN/AView Earnings Details
11/12/2013Q3($0.17)($0.15)ViewN/AView Earnings Details
11/13/2012Q312($0.01)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Synergy Pharmaceuticals (NASDAQ:SGYP)
Current Year EPS Consensus Estimate: $-1.03 EPS
Next Year EPS Consensus Estimate: $-0.47 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.19)($0.19)($0.19)
Q2 20161($0.25)($0.25)($0.25)
Q3 20161($0.25)($0.25)($0.25)
Q4 20161($0.18)($0.18)($0.18)
(Data provided by Zacks Investment Research)


Dividend History for Synergy Pharmaceuticals (NASDAQ:SGYP)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Synergy Pharmaceuticals (NASDAQ:SGYP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2015Bernard DenoyerSVPSell10,000$7.50$75,000.00View SEC Filing  
9/11/2015Alan JoslynDirectorSell13,754$7.22$99,303.88View SEC Filing  
6/3/2014John P BrancaccioDirectorBuy3,500$4.12$14,420.00View SEC Filing  
5/27/2014Gary S JacobCEOBuy4,000$4.18$16,720.00View SEC Filing  
5/23/2014Bernard DenoyerSVPBuy2,500$3.89$9,725.00View SEC Filing  
5/23/2014Kunwar ShailubhaiInsiderBuy3,000$3.89$11,670.00View SEC Filing  
10/29/2013Gabriel CerroneDirectorBuy12,000$4.09$49,080.00View SEC Filing  
6/21/2013Bernard DenoyerSVPBuy7,500$4.78$35,850.00View SEC Filing  
6/14/2013Gabriel CerroneChairmanBuy8,000$4.42$35,360.00View SEC Filing  
4/24/2013Gabriel CerroneChairmanBuy5,500$4.66$25,630.00View SEC Filing  
2/5/2013Gabriel CerroneChairmanBuy5,000$6.15$30,750.00View SEC Filing  
2/4/2013Gabriel CerroneChairmanBuy13,090$6.04$79,063.60View SEC Filing  
1/30/2013Gabriel CerroneChairmanBuy26,000$5.98$155,480.00View SEC Filing  
11/14/2012Gabriel CerroneChairmanBuy87,820$3.61$317,030.20View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Synergy Pharmaceuticals (NASDAQ:SGYP)
News IconKeep an eye on Active stock of Yesterday- Synergy Pharmaceuticals, Inc.'s (SGYP) - Hot Stocks Point (NASDAQ:SGYP) - August 30 at 10:37 AM
News IconHC Stocks Highlights: Synergy Pharmaceuticals Inc (SGYP), Hologic, Inc. (HOLX) - share market updates (press release) (NASDAQ:SGYP) - August 25 at 7:36 PM
News IconSynergy Pharmaceuticals, Inc.'s (SGYP): Reviewing Hot Stock of Yesterday - Hot Stocks Point (NASDAQ:SGYP) - August 25 at 12:31 PM logoTrader's Round Up: Synergy Pharmaceuticals, Inc. (SGYP), Sabre ... - iStreetWire (NASDAQ:SGYP) - August 23 at 7:31 PM logoSGYP April 2017 Options Begin Trading (NASDAQ:SGYP) - August 22 at 11:57 AM logoTraders Recap: Exxon Mobil Corporation (XOM), Synergy Pharmaceuticals, Inc. (SGYP), The Home Depot, Inc. (HD) - iStreetWire (NASDAQ:SGYP) - August 16 at 7:29 PM logoSynergy Pharmaceuticals Inc (SGYP): A Small-Cap Biotech With Momo On Its Side (NASDAQ:SGYP) - August 15 at 12:33 PM
News IconHC Stocks Growth: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Allergan plc Ordinary Shares (NYSE:AGN) - share market updates (press release) (NASDAQ:SGYP) - August 10 at 10:33 AM
News IconMost Volatile DrugMakers- MEI Pharma (NASDAQ:MEIP), Synergy Pharmaceuticals (NASDAQ:SGYP) - Seneca Globe (NASDAQ:SGYP) - August 10 at 10:33 AM logoTwo Movers within Analysts Observation: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) , Ionis Pharmaceuticals Inc ... - Street Updates (NASDAQ:SGYP) - August 10 at 10:33 AM
News IconActivision Blizzard, (NASDAQ:ATVI) & Synergy Pharmaceuticals (NASDAQ:SGYP) Eye-Catching Stocks - Money News (press release) (NASDAQ:SGYP) - August 10 at 10:33 AM logoAnalysts Ranking Previews: Aratana Therapeutics, Inc. (NASDAQ:PETX) , Synergy Pharmaceuticals, Inc. (NASDAQ ... - Street Updates (NASDAQ:SGYP) - August 10 at 10:33 AM logoSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Insiders Look Pessimistic About Prospects - Review Fortune (NASDAQ:SGYP) - August 10 at 10:33 AM
News IconRevenue Estimates Analysis: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - News Oracle (NASDAQ:SGYP) - August 10 at 10:33 AM logoSynergy Pharma (SGYP) Posts Q2 Loss of $0.23/Share (NASDAQ:SGYP) - August 8 at 7:36 PM
News IconSynergy Pharmaceuticals Reports Second Quarter 2016 Financial Results and Business Update (NASDAQ:SGYP) - August 8 at 7:36 PM logoSynergy Pharmaceuticals : Pharma reports 2Q loss (NASDAQ:SGYP) - August 8 at 7:36 PM logoSynergy Pharma reports 2Q loss (NASDAQ:SGYP) - August 8 at 7:36 PM logoSynergy Pharmaceuticals Inc. (SGYP) Jumps 8.06% on August 05 - (NASDAQ:SGYP) - August 6 at 10:04 AM logoAnalysts Rating Overview: Abbott Laboratories (NYSE:ABT) , Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Street Updates (NASDAQ:SGYP) - August 5 at 10:25 AM logoStock's Ratings to Focus: CVS Health Corporation (NYSE:CVS) , Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Street Updates (NASDAQ:SGYP) - August 4 at 7:51 PM logoSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Stock Rises, Analysts: Buy Rating - Review Fortune (NASDAQ:SGYP) - August 2 at 7:44 PM logoSynergy Pharmaceuticals to Present at Canaccord Genuity 36th Annual Growth Conference (NASDAQ:SGYP) - August 1 at 1:01 PM logoRecent Analysts Ratings of Stocks: CVS Health Corporation (NYSE:CVS) , Synergy Pharmaceuticals, Inc. (NASDAQ ... - Street Updates (NASDAQ:SGYP) - July 28 at 7:40 PM logoSynergy Pharmaceuticals: Attractive Acquisition Target - Seeking Alpha (NASDAQ:SGYP) - July 28 at 7:40 PM logoCurrent Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) PT Means ... - Review Fortune (NASDAQ:SGYP) - July 27 at 7:48 PM logoAnalyst Recommendations On Watch List: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Big Lots, Inc. (NYSE:BIG) - Review Fortune (NASDAQ:SGYP) - July 26 at 10:46 AM logoSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Stock Rises ... - Review Fortune (NASDAQ:SGYP) - July 25 at 7:31 PM
News IconHow Many Synergy Pharmaceuticals Inc (NASDAQ:SGYP)'s Analysts Are Bullish? - Press Telegraph (NASDAQ:SGYP) - July 23 at 11:10 AM
News IconSynergy Pharmaceuticals DE (NASDAQ:SGYP) Shorted Shares Increased By 32.05% - Press Telegraph (NASDAQ:SGYP) - July 22 at 7:09 PM logoAnalyst Rating Fluctuations to Observe: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) , Cerus Corporation ... - Street Updates (NASDAQ:SGYP) - July 22 at 10:19 AM
News IconRecommendation Trends to See: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - News Oracle (NASDAQ:SGYP) - July 22 at 10:19 AM logoHave a look at Analyst Actions: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) , Cigna Corporation (NYSE:CI) - Street Updates (NASDAQ:SGYP) - July 20 at 8:18 PM
News IconSynergy Pharmaceuticals Inc Just Recorded A Sigfniciant Increase - Press Telegraph (NASDAQ:SGYP) - July 20 at 8:18 PM logoSynergy Pharmaceuticals Inc. (SGYP) Jumps 5.52% on July 20 - (NASDAQ:SGYP) - July 20 at 8:18 PM logoRodman & Renshaw Analyst Remains Bullish on Synergy Pharmaceuticals Inc (SGYP); Anticipating FDA Approval for ... - Smarter Analyst (NASDAQ:SGYP) - July 19 at 7:33 PM
News IconInvestor Watch: Volatility Recap on Shares of: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Engelwood Daily (NASDAQ:SGYP) - July 19 at 9:34 AM
News IconHC Stocks in Hub: Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Medtronic PLC (NYSE:MDT) - share market updates (press release) (NASDAQ:SGYP) - July 18 at 12:59 PM logoBTIG Analyst Remains Bullish On Synergy Pharmaceuticals Inc (SGYP) Despite NDA Filing Delay - Smarter Analyst (NASDAQ:SGYP) - July 18 at 12:59 PM
News IconEye Catching Stock: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - News Oracle (NASDAQ:SGYP) - July 18 at 12:59 PM logoBiotech Movers: Elite Pharmaceuticals Inc (ELTP) and Synergy Pharmaceuticals Inc (SGYP) (NASDAQ:SGYP) - July 18 at 12:15 PM
News IconShares Experiencing a Downtrend: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - TGP (NASDAQ:SGYP) - July 17 at 11:27 AM logoSynergy Pharma (SGYP) Reaches FDA Mid-Cycle Review for Plecanatide NDA; Will Continue Enrollment in Phase 3 for IBS-C (NASDAQ:SGYP) - July 17 at 11:27 AM logo4 Companies That Destroyed Shareholders Last Week (NASDAQ:SGYP) - July 17 at 10:40 AM
News IconShares Moving Down on the Week: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Engelwood Daily (NASDAQ:SGYP) - July 16 at 6:48 PM logoSynergy Pharmaceuticals Sinks on FDA Update - 24/7 Wall St. (NASDAQ:SGYP) - July 16 at 6:48 PM logoCanaccord Weighs In on Synergy Pharmaceuticals Inc (SGYP) Following Regulatory and Clinical Updates - Smarter Analyst (NASDAQ:SGYP) - July 16 at 6:48 PM logoSynergy Pharmaceuticals Offers Update On Ongoing Irritable Bowel Syndrome With Constipation Program (NASDAQ:SGYP) - July 16 at 10:36 AM
News IconSynergy Pharmaceuticals Sinks on FDA Update (NASDAQ:SGYP) - July 16 at 9:48 AM logoSynergy Pharmaceuticals (SGYP) Stock Slides Despite FDA Updates (NASDAQ:SGYP) - July 15 at 1:56 PM


Synergy Pharmaceuticals (NASDAQ:SGYP) Chart for Tuesday, August, 30, 2016

Last Updated on 8/30/2016 by Staff